© PR Newswire
24.06.2025
AUTL
LISTED
NASDAQ
Wall Street Eyes Breakout Cancer Therapies Amid Soaring Drug Prices
News Preview
Equity Insider News Commentary
Issued on behalf of Oncolytics Biotech Inc.
VANCOUVER, BC, June 24, 2025 /PRNewswire/ -- Equity Insider News Commentary – Rising rates of cancer are going to come at a major cost, and it's looking more and more like the solution is going to have to come from the private sector. Recent reports suggest the U.S. govern...
Themefolio
Profiler
Peergroup
© PR Newswire
24.06.2025
AUTL
LISTED
NASDAQ
Wall Street Eyes Breakout Cancer Therapies Amid Soaring Drug Prices
News Preview
Equity Insider News Commentary
Issued on behalf of Oncolytics Biotech Inc.
VANCOUVER, BC, June 24, 2025 /PRNewswire/ -- Equity Insider News Commentary – Rising rates of cancer are going to come at a major cost, and it's looking more and more like the solution is going to have to come from the private sector. Recent reports suggest the U.S. govern...
Themefolio
Profiler
Peergroup
© PR Newswire
24.06.2025
AUTL
LISTED
NASDAQ
Wall Street Eyes Breakout Cancer Therapies Amid Soaring Drug Prices
News Preview
Equity Insider News Commentary
Issued on behalf of Oncolytics Biotech Inc.
VANCOUVER, BC, June 24, 2025 /CNW/ -- Equity Insider News Commentary – Rising rates of cancer are going to come at a major cost, and it's looking more and more like the solution is going to have to come from the private sector. Recent reports suggest the U.S. government ma...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
24.06.2025
CLARI
LISTED
EURONEXT
Clariane has successfully completed a bond issue of 400 million euros
News Preview
...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
24.06.2025
HLN
LISTED
LSE
HALEON APPOINTS CARL HANEY AS CHIEF R&D OFFICER
News Preview
LONDON, June 24, 2025 /PRNewswire/ -- Haleon (LSE: HLN) (NYSE: HLN) today announces the appointment of Carl Haney as Chief Research & Development Officer. Carl will join Haleon on 1 August 2025.
This appointment follows Franck Riot deciding to leave Haleon after six years in the business.
Carl joins Haleon from the Estée Lauder Companies I...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.06.2025
SN
LISTED
LSE
Smith+Nephew’s new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing’ to trauma surgeons repairing tibial fractures
News Preview
The future of fracture fixation with novel side-specific nails featuring variable angle locking technology...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.06.2025
REC
LISTED
EURONEXT
RECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO COMMERCIALIZE VAZKEPA® IN EUROPE
News Preview
RECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO COMMERCIALIZE VAZKEPA® IN EUROPE...
Themefolio
Profiler
Peergroup
© Newsfile
24.06.2025
COPN
LISTED
SIX
Cosmo to Unveil First-of-its-Kind Clinical Study on the Use of GI Genius(TM) with Apple Vision Pro at Rush University Medical Center
News Preview
Dublin, Ireland--(Newsfile Corp. - June 24, 2025) - Cosmo Pharmaceuticals N.V. (“Cosmo”) today announced that in July 2025, it will initiate their first usability study of a medical device software application connecting the Medtronic GI Genius™ intelligent endoscopy module, an AI-powered platform for gastrointestinal e...
Themefolio
Profiler
Peergroup
© BusinessWire
24.06.2025
TEM
LISTED
NASDAQ
Law Offices of Howard G. Smith Encourages Tempus AI, Inc. (TEM) Investors To Inquire About Securities Fraud Class Action
News Preview
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Tempus AI, Inc. (“Tempus” or the “Company”) (NASDAQ: TEM) common stock between August 6, 2024 and May 27, 2025, inclusive (the “Class Period”). Tempus investors have until August 12, 2025 to file a lead plaintiff motion.
IF YO...
Themefolio
Profiler
Peergroup
© BusinessWire
23.06.2025
TEM
LISTED
NASDAQ
Law Offices of Frank R. Cruz Encourages Tempus AI, Inc. (TEM) Investors To Inquire About Securities Fraud Class Action
News Preview
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Tempus AI, Inc. (“Tempus” or the “Company”) (NASDAQ: TEM) common stock between August 6, 2024 and May 27, 2025, inclusive (the “Class Period”). Tempus investors have until August 12, 2025 to file a lead plaintiff motion.
IF...
Themefolio
Profiler
Peergroup
© PR Newswire
23.06.2025
ATNM
LISTED
XASE
Actinium Highlights Expanded Data Set for ATNM-400 in Prostate Cancer Demonstrating Superior Efficacy to Enzalutamide and Ability to Overcome Resistance to ARPI Therapy and PSMA-Ac-225/Lu-177 Labelled Radiotherapy at the Society of Nuclear Medicine &
News Preview
- ATNM-400 shows; superior prostate cancer cell killing compared to androgen receptor inhibitor Xtandi® (enzalutamide), the ability to overcome Xtandi resistance, and activity in combination
- ATNM-400 is more efficacious than both Pluvicto® (177-Lu-PSMA-617) and Ac-225-PSMA-617 targeted radiotherapy in prostate cancer in vitro and in vivo mode...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.06.2025
NSIS B
LISTED
CPH
Major shareholder announcement
News Preview
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments....
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
23.06.2025
ICLR
LISTED
NASDAQ
ICON plc Schedules Second Quarter 2025 Earnings Conference Call
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that it will release its financial results for the second quarter 2025 after the market closes on Wednesday, July 23, 2025. The company will hold a conference call and webcast to discuss its financial results and performance...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.06.2025
GMAB
LISTED
CPH
Transactions in Connection with Share Buy-back Program
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.06.2025
SN
LISTED
LSE
Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the appointment of Ajay Dhankhar, PhD, as Chief Corporate Development & Strategy Officer, effective today. Ajay will report to Chief Executive Officer Deepak Nath and join the Smith+Nephew Executive Committee. ...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.06.2025
GLPG
LISTED
EURONEXT
Galapagos Appoints Aaron Cox as Chief Financial Officer
News Preview
Former Horizon CFO joins Galapagos with deep expertise in international corporate finance, M&A, business development and strategic leadership ...
Themefolio
Profiler
Peergroup
© BusinessWire
20.06.2025
TEM
LISTED
NASDAQ
Securities Fraud Investigation Into Tempus AI, Inc. (TEM) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Tempus AI, Inc. (“Tempus” or the “Company”) (NASDAQ: TEM) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON TEMPUS AI, I...
Themefolio
Profiler
Peergroup
© BusinessWire
20.06.2025
TEM
LISTED
NASDAQ
INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - TEM
News Preview
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Tempus AI, Inc. (NASDAQ: TEM) common stock between August 6, 2024 and May 27, 2025, inclusive (the “Class Period”), have until August 12, 2025 to seek appointment as lead plaintiff of the Tempus AI class action lawsuit. Captioned Shouse v. Tempus AI, Inc., No. 25-cv-...
Themefolio
Profiler
Peergroup
© BusinessWire
20.06.2025
TEM
LISTED
NASDAQ
Tempus AI, Inc. (TEM) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of Tempus AI, Inc. (“Tempus” or the “Company”) (NASDAQ: TEM) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN TEMPUS AI, INC. (TEM), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSU...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.06.2025
OSE
LISTED
EURONEXT
OSE Immunotherapeutics Reaffirms Commitment to Holding a Transparent and Serene General Meeting in Compliance with Market Rules
News Preview
OSE Immunotherapeutics Reaffirms Commitment to Holding a Transparent and Serene General Meeting in Compliance with Market Rules...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.06.2025
ORNBV
LISTED
HEL
CHMP recommends third indication for darolutamide for patients with advanced prostate cancer
News Preview
ORION CORPORATION PRESS RELEASE 20 JUNE 2025 at 13.30 EEST ...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.06.2025
MDGL
LISTED
NASDAQ
Madrigal Receives Positive CHMP Opinion for Resmetirom (Rezdiffra™) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis
News Preview
CONSHOHOCKEN, Pa., June 20, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)...
Themefolio
Profiler
Peergroup
© EQS Newswire
20.06.2025
FYB
LISTED
XETR
Public subscription now also possible via Deutsche Börse
News Preview
Press Release // June 20, 2025
Formycon bond 2025/2029: Public subscription now also possible via Deutsche Börse
The subscription period via Deutsche Börse AG's DirectPlace is now open and will close on 30 June 2025 at 12:00 p.m. CEST (subject to early closure)
The unsecured senior bond has a target volume of €50 million and carries a variable i......
Themefolio
Profiler
Peergroup
© EQS Newswire
20.06.2025
FYB
LISTED
XETR
Öffentliche Zeichnung jetzt auch direkt über die Deutsche Börse möglich
News Preview
Pressemitteilung // 20. Juni 2025
Formycon-Anleihe 2025/2029: Öffentliche Zeichnung jetzt auch direkt über die Deutsche Börse möglich
Zeichnungsfrist via DirectPlace der Deutsche Börse AG läuft ab sofort bis zum 30. Juni 2025, 12:00 Uhr MESZ (vorzeitige Schließung vorbehalten)
Die unbesicherte Anleihe hat ein Zielvolumen von 50 Mio. Euro und ist......
Themefolio
Profiler
Peergroup
© PR Newswire
20.06.2025
SOBI
LISTED
STO
Sobi will showcase extensive research and clinical outcomes at ISTH 2025
News Preview
STOCKHOLM, June 20, 2025 /PRNewswire/ -- Sobi® (STO: SOBI) will be presenting a wide range of clinical study updates at the annual International Society on Thrombosis and Haemostasis (ISTH) Congress in Washington (21-25 June). With ten (10) presentations, Sobi's clinical teams will showcase new data for avatrombopag to treat children with ITP, su...
Themefolio
Profiler
Peergroup
© PR Newswire
19.06.2025
INDV
LISTED
NASDAQ
Indivior Presents New Data at CPDD Demonstrating that High Buprenorphine Exposure May Improve Treatment Outcomes in High Fentanyl Users
News Preview
A post-hoc analysis demonstrates that buprenorphine exposure with 300 mg SUBLOCADE® (buprenorphine extended-release) may improve treatment outcomes among opioid use disorder (OUD) patients with heavy fentanyl use1Additional Indivior-funded research identified OUD treatment barriers in American Indian/Alaska Native (AI/AN) people who are often aff...
Themefolio
Profiler
Peergroup
© ActuNews
19.06.2025
OXUR
LISTED
EURONEXT
Oxurion signe une lettre d'intention pour l'acquisition projetée d'une CRO de services précliniques en microbiologie afin de se diversifier et de renforcer sa présence en région toulousaine
News Preview
Louvain, Belgique, 19 juin 2025 à 8h30, Oxurion NV (Euronext Bruxelles : OXUR), entreprise biopharmaceutique basée à Louvain, annonce la signature d'une lettre d'intention (LOI) d''acquisition de 70 % du capital d'une société spécialisée dans les services préclini...
Themefolio
Profiler
Peergroup
© ActuNews
19.06.2025
OXUR
LISTED
EURONEXT
Oxurion signs a letter of intent for the planned acquisition of a preclinical microbiology CRO to diversify and strengthen its presence in the Toulouse region
News Preview
Leuven, BELGIUM – June 19, 2025 at 8:30 AM CET, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company based in Leuven, announces the signing of a letter of intent (LOI) to acquire 70% of the share capital of a company specialized in preclinical microbiology services for human and animal health, dermocosmetics, and nutraceuticals....
Themefolio
Profiler
Peergroup
© ActuNews
19.06.2025
OXUR
LISTED
EURONEXT
Oxurion ondertekent intentieverklaring voor de voorgenomen overname van een preklinische microbiologie-CRO om zich te diversifiëren en zijn aanwezigheid in de regio Toulouse te versterken
News Preview
Leuven, BELGIË – 19 juni 2025 – 8u30 CET – Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, kondigt de ondertekening aan van een intentieverklaring (LOI) voor de overname van 70% van het aandelenkapitaal van een onderneming gespecialiseerd in preklinische microbiologische diensten...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.06.2025
NSIS B
LISTED
CPH
Major shareholder announcement
News Preview
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments....
Themefolio
Profiler
Peergroup
© BusinessWire
19.06.2025
TEM
LISTED
NASDAQ
Securities Fraud Investigation Into Tempus AI, Inc. (TEM) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of Tempus AI, Inc. (“Tempus” or the “Company”) (NASDAQ: TEM) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON TEMPUS AI, INC. (TEM), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVE...
Themefolio
Profiler
Peergroup
© BusinessWire
18.06.2025
SLP
LISTED
NASDAQ
Simulations Plus Announces Rescheduling of Third Quarter Fiscal 2025 Earnings Release and Conference Call
News Preview
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that it has rescheduled the release of its financial results and conference call for the t...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.06.2025
GLPG
LISTED
EURONEXT
Galapagos Presented New Data at ICML 2025 From Cohort 3 of ATALANTA-1 in Relapsed/Refractory Indolent NHL Patients, Demonstrating High Complete Response and MRD Negativity Rates With CAR-T Candidate GLPG5101
News Preview
Of the 34 patients enrolled in Cohort 3 of the ATALANTA-1 Phase 1/2 study, 32 received GLPG5101; 94% were infused with fresh CAR-T cells, and 93% were treated within seven days of manufacturing...
Themefolio
Profiler
Peergroup
© EQS Newswire
18.06.2025
ILM1
LISTED
XETR
Medios adopts public share buyback offer for up to 1 million shares at a price of EUR 12.50
News Preview
NOT FOR DISTRIBUTION OR DISSEMINATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR DISSEMINATION WOULD BE UNLAWFUL. FURTHER RESTRICTIONS APPLY. PLEASE SEE THE IMPORTANT NOTE AT THE END OF THIS AD HOC ANNOUNCEMENT.
Ad hoc publication
Disclosure......
Themefolio
Profiler
Peergroup
© EQS Newswire
18.06.2025
ILM1
LISTED
XETR
Medios AG beschließt öffentliches Aktienrückkaufangebot für bis zu 1 Million Aktien zum Preis von EUR 12,50
News Preview
NICHT ZUR WEITERLEITUNG ODER VERBREITUNG, WEDER DIREKT NOCH INDIREKT, IN ODER INNERHALB DER VEREINIGTEN STAATEN VON AMERIKA, KANADA, AUSTRALIEN ODER JAPAN ODER ANDEREN JURISDIKTIONEN, IN DENEN DIE WEITERLEITUNG ODER VERBREITUNG RECHTSWIDRIG WÄRE. ES GELTEN WEITERE BESCHRÄNKUNGEN. BITTE BEACHTEN SIE DEN WICHTIGEN HINWEIS AM ENDE DIESER AD-HOC-MITTEI......
Themefolio
Profiler
Peergroup
© ActuNews
18.06.2025
OXUR
LISTED
EURONEXT
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
News Preview
Leuven, BELGIË – 18 juni 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgeving heeft ontvangen:
Oxurion ontving een transparanti...
Themefolio
Profiler
Peergroup
© ActuNews
18.06.2025
OXUR
LISTED
EURONEXT
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
News Preview
Leuven, BELGIUM – June 18, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows:
Oxurion received a transparency notification on June 16, 2025, from Atlas...
Themefolio
Profiler
Peergroup
© EQS Newswire
18.06.2025
FYB
LISTED
XETR
Ordentliche Hauptversammlung der Formycon AG stimmt allen Beschlussvorschlägen mit großen Mehrheiten zu
News Preview
Pressemitteilung // 18. Juni 2025
Ordentliche Hauptversammlung der Formycon AG stimmt allen Beschlussvorschlägen mit großen Mehrheiten zu
Vorstand berichtet ausführlich über Geschäftsjahr 2024 und gibt Ausblick für 2025
Aufsichtsrat wird auf sechs Mitglieder erweitert; Klaus Röhrig wiedergewählt
Dr. Graham Keith Dixon als neues Mitglied in de......
Themefolio
Profiler
Peergroup
© EQS Newswire
18.06.2025
FYB
LISTED
XETR
Ordinary Annual General Meeting of Formycon AG approves all proposed resolutions by large majorities
News Preview
Press Release // June 18, 2025
Ordinary Annual General Meeting of Formycon AG approves all proposed resolutions by large majorities
Management provides detailed report on financial year 2024 and provides outlook for 2025
Supervisory Board expands to six members; Klaus Röhrig re-elected
Dr. Graham Keith Dixon elected as a new member of the Sup......
Themefolio
Profiler
Peergroup
© EQS Newswire
18.06.2025
EUZ
LISTED
XETR
Hauptversammlung der Eckert & Ziegler SE beschließt 0,50 EUR Dividende
News Preview
Berlin, 18.06.2025. Die ordentliche Hauptversammlung der Eckert & Ziegler SE (ISIN DE0005659700) hat heute den Vorschlag von Vorstand und Aufsichtsrat angenommen und eine Dividende von 0,50 Euro je Aktie für das Geschäftsjahr 2024 beschlossen.
Wie bereits im Vorjahr fand die Hauptversammlung als Präsenzveranstaltung am Sitz der Eckert & Z......
Themefolio
Profiler
Peergroup
© EQS Newswire
18.06.2025
EUZ
LISTED
XETR
Annual General Meeting of Eckert & Ziegler SE Approves Dividend of EUR 0.50
News Preview
Berlin, June 18, 2025. The Annual General Meeting of Eckert & Ziegler SE (ISIN DE0005659700) today approved the proposal of the Executive Board and Supervisory Board and resolved to pay a dividend of EUR 0.50 per share for the 2024 fiscal year.
As in the previous year, the Annual General Meeting was held as an in-person event at Eckert & Z......
Themefolio
Profiler
Peergroup
© BusinessWire
18.06.2025
ERF
LISTED
EURONEXT
Eurofins Scientific SE: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS...
Themefolio
Profiler
Peergroup
© PR Newswire
18.06.2025
CAMX
LISTED
STO
Camurus' POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients
News Preview
CAM2029 reduces liver and cyst volume growth compared to placebo Well tolerated with no new or unexpected safety findingsA follow-up Phase 3 study will be discussed with regulatory authoritiesLUND, Sweden, June 18, 2025 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced topline results from the 12-month, randomized, double-blind, placebo-...
Themefolio
Profiler
Peergroup
© PR Newswire
18.06.2025
CAMX
LISTED
STO
Camurus' POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients
News Preview
CAM2029 reduces liver and cyst volume growth compared to placebo Well tolerated with no new or unexpected safety findingsA follow-up Phase 3 study will be discussed with regulatory authoritiesLUND, Sweden, June 18, 2025 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced topline results from the 12-month, randomized, double-blind, placebo-...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.06.2025
SN
LISTED
LSE
Smith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UK
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a strategic partnership with Standard Health www.standardhealth.co.uk to support the development of the first-ever Orthopaedic Ambulatory Surgery Centre in the UK. Based in Poole, Dorset, the new centre will offer NHS and private patients access to leading joint...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.06.2025
BAVA
LISTED
CPH
Bavarian Nordic Announces Sale of Priority Review Voucher for USD 160 Million
News Preview
COPENHAGEN, Denmark, June 18, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that it has entered into an agreement to sell its Priority Review Voucher (PRV) for a total cash consideration of USD 160 million....
Themefolio
Profiler
Peergroup
© EQS Newswire
18.06.2025
FYB
LISTED
XETR
Zeichnung der Unternehmensanleihe 2025/2029 gestartet
News Preview
Pressemitteilung // 18. Juni 2025
Formycon AG: Zeichnung der Unternehmensanleihe 2025/2029 gestartet
Planegg-Martinsried – Die Formycon AG (FWB: FYB, Prime Standard, „Formycon") gibt bekannt, dass der Wertpapierprospekt am 17. Juni durch die luxemburgische Finanzaufsichtsbehörde CSSF gebilligt wurde und die Unternehmensanleihe 2025/2029 (ISIN NO0......
Themefolio
Profiler
Peergroup
© EQS Newswire
18.06.2025
FYB
LISTED
XETR
Subscription period for 2025/2029 corporate bond has started
News Preview
Press Release // June 18, 2025
Formycon AG: Subscription period for 2025/2029 corporate bond has started
Planegg-Martinsried, Germany – Formycon AG (FSE: FYB, Prime Standard, “Formycon”) announces that the securities prospectus for the newly issued corporate bond 2025/2029 (ISIN NO0013586024 / WKN A4DFJH) has been approved by the Luxembourg finan......
Themefolio
Profiler
Peergroup
© Globe Newswire
18.06.2025
IBAB
LISTED
EURONEXT
Steri-Tek to boost sterilization capacity of its Texas-based center fivefold with IBA’s X-ray irradiation system
News Preview
Louvain-la-Neuve, Belgium, June 18, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and electron beam and X-ray solutions for industrial advanced irradiation, announced today it has signed a contract with Steri-Tek, a growing irradiation services provider, to install a fully-integrated Be Wide...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.06.2025
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
News Preview
CONSHOHOCKEN, Pa., June 17, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on June 15, 2025 to 36 new non-executive employees as equity inducement a...
Themefolio
Profiler
Peergroup
© EQS Newswire
17.06.2025
GXI
LISTED
XETR
Gerresheimer AG reacts to media reports
News Preview
Gerresheimer AG reacts to media reports
Düsseldorf, June 17, 2025. Gerresheimer AG (ISIN: DE000A0LD6E6) reacts to media reports that KPS Capital Partners has decided against teaming up with Warburg Pincus on a potential public take-over offer for Gerresheimer AG.
KPS Capital Partners has informed Gerresheimer AG upon request that they are still i......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.06.2025
GXI
LISTED
XETR
Gerresheimer AG reagiert auf Medienberichte
News Preview
Gerresheimer AG reagiert auf Medienberichte
Düsseldorf, 17. Juni 2025. Gerresheimer AG (ISIN: DE000A0LD6E6) reagiert auf Medienberichte, wonach KPS Capital Partners sich gegen eine Zusammenarbeit mit Warburg Pincus im Hinblick auf ein mögliches öffentliches Übernahmeangebot für die Gerresheimer AG entschieden habe.
KPS Capital Partners hat der Ge......
Themefolio
Profiler
Peergroup
© Globe Newswire
17.06.2025
GNFT
LISTED
EURONEXT
GENFIT: June 17, 2025 Combined Shareholders Meeting Results
News Preview
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), June 17, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the results of the Combined Shareholders Meeting which took place on June 17, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.06.2025
GMAB
LISTED
CPH
Capital Increase in Genmab as a Result of Employee Warrant Exercise
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© BusinessWire
17.06.2025
ERF
LISTED
EURONEXT
Eurofins Scientific SE: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSAC...
Themefolio
Profiler
Peergroup
© EQS Newswire
17.06.2025
DIM
LISTED
EURONEXT
Sartorius Stedim Biotech expands manufacturing and R&D capacities for innovative bioprocess solutions in France
News Preview
Sartorius Stedim Biotech SA
/ Key word(s): Expansion
Sartorius Stedim Biotech expands manufacturing and R&D capacities for innovative bioprocess solutions in France 17-Jun-2025 / 16:00 CET/CEST
Aubagne, France | June 17, 2025Sartorius Stedim Biotech expands manufacturing and R&D capacities for innovative bioprocess so......
Themefolio
Profiler
Peergroup
© PR Newswire
17.06.2025
CU6
LISTED
ASX
Clarity enters a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with SpectronRx
News Preview
Highlights
Clarity has entered into a Commercial Manufacturing Agreement with SpectronRx for 64Cu-SAR-bisPSMA.SpectronRx's facility in Indiana will provide on-demand commercial-scale manufacturing of both copper-64 and 64Cu-SAR-bisPSMA under one roof and enables distribution to all 50 states.SpectronRx will expand current production to up to 400,...
Themefolio
Profiler
Peergroup
© BusinessWire
17.06.2025
TEM
LISTED
NASDAQ
Tempus to Participate in TD Cowen’s 4th Annual Tools/Dx Revolution Conference
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in TD Cowen's/Securities' 4th Annual Tools/Dx Revolution conference. The event is taking place on June 22 - 25, 2025, in Dana Point, California. Jim Rogers, Chief Financial Officer of Tempus, will join the...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.06.2025
ORY
LISTED
BME
ORYZON to Attend the 2025 Phelan-McDermid Syndrome (PMS) Congress in Barcelona on June 26-29
News Preview
MADRID and CAMBRIDGE, Mass., June 17, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, announced today that its Chief Scientific Officer, Dr. Jordi Xaus will be attending the 2025 Phelan-McDermid Syndrome Congress in Barcelona on June 26...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.06.2025
SKYE
LISTED
NASDAQ
Skye Bioscience to Present Expanded Preclinical CB1 Antibody Data at the American Diabetes Association’s 85th Scientific Sessions
News Preview
SAN DIEGO, June 17, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that it was selected to present new nimacimab data in its expanded preclinical model at the upcoming Amer...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
